VYNE Therapeutics Announces New U.S. Patent Expiring in 2037 for AMZEEQ® (minocycline) topical foam, 4% December 15, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on VYNE Therapeutics Announces New U.S. Patent Expiring in 2037 for AMZEEQ® (minocycline) topical foam, 4% New Granted Patent Listed in FDA’s Orange Book for AMZEEQ New Granted Patent Listed in FDA’s Orange Book for AMZEEQ